BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Onishi K. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol 2017;70:128-34. [PMID: 28325523 DOI: 10.1016/j.jjcc.2017.03.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lévy S, Steinbeck G, Santini L, Nabauer M, Maceda DP, Kantharia BK, Saksena S, Cappato R. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society. J Interv Card Electrophysiol 2022. [PMID: 35419669 DOI: 10.1007/s10840-022-01195-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Luo Y, Tan N, Zhao J, Li Y. A Nomogram for Predicting In-Stent Restenosis Risk in Patients Undergoing Percutaneous Coronary Intervention: A Population-Based Analysis. IJGM 2022;Volume 15:2451-61. [DOI: 10.2147/ijgm.s357250] [Reference Citation Analysis]
3 Shibata N, Kondo T, Morimoto R, Kazama S, Sawamura A, Nishiyama I, Kato T, Kuwayama T, Hiraiwa H, Umemoto N, Asai T, Okumura T, Murohara T. Clinical value of the HATCH score for predicting adverse outcomes in patients with heart failure. Heart Vessels. [DOI: 10.1007/s00380-022-02035-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ezponda A, Casanova C, Divo M, Marín-Oto M, Cabrera C, Marín JM, Bastarrika G, Pinto-Plata V, Martin-Palmero Á, Polverino F, Celli BR, de Torres JP. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort. Respirology 2022. [PMID: 35132732 DOI: 10.1111/resp.14223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Sorgente A, Farkowski MM, Iliodromitis K, Guerra JM, Jubele K, Chun JKR, de Asmundis C, Boveda S. Contemporary clinical management of monomorphic idiopathic premature ventricular contractions: results of the European Heart Rhythm Association Survey. EP Europace 2022. [DOI: 10.1093/europace/euab307] [Reference Citation Analysis]
6 Jurevičienė E, Burneikaitė G, Dambrauskas L, Kasiulevičius V, Kazėnaitė E, Navickas R, Puronaitė R, Smailytė G, Visockienė Ž, Danila E. Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) Comorbidities in Lithuanian National Database: A Cluster Analysis. Int J Environ Res Public Health 2022;19:970. [PMID: 35055792 DOI: 10.3390/ijerph19020970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ahn I, Gwon H, Kang H, Kim Y, Seo H, Choi H, Cho HN, Kim M, Jun TJ, Kim YH. Machine Learning-Based Hospital Discharge Prediction for Patients With Cardiovascular Diseases: Development and Usability Study. JMIR Med Inform 2021;9:e32662. [PMID: 34787584 DOI: 10.2196/32662] [Reference Citation Analysis]
8 Alhamed Alduihi F. ECG Abnormalities in Patients with Acute Exacerbation of Bronchiectasis and Factors Associated with High Probability of Abnormality. Pulm Med 2021;2021:6649572. [PMID: 34327019 DOI: 10.1155/2021/6649572] [Reference Citation Analysis]
9 Kalmin MM, Westreich D, Drummond BM, Sun J, Mehta SH, Kirk GD. Incident obstructive lung disease and mortality among people with HIV and a history of injecting drugs. AIDS 2021;35:1451-60. [PMID: 33831913 DOI: 10.1097/QAD.0000000000002914] [Reference Citation Analysis]
10 Scosyrev E, van Zyl-Smit R, Kerstjens H, Gessner C, Kornmann O, Jain D, Aubrun E, D'Andrea P, Hosoe M, Pethe A, Brittain D. Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials. Respir Med 2021;180:106311. [PMID: 33711782 DOI: 10.1016/j.rmed.2021.106311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ji Z, Hernández-Vázquez J, Domínguez-Zabaleta IM, Xia Z, Bellón-Cano JM, Gallo-González V, Ali-García I, Matesanz-Ruiz C, López-de-Andrés A, Jiménez-García R, Buendía-García MJ, Gómez-Sacristán Á, Girón-Matute WI, Puente-Maestu L, de Miguel-Díez J. Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes. Int J Chron Obstruct Pulmon Dis 2020;15:2759-67. [PMID: 33154636 DOI: 10.2147/COPD.S270770] [Reference Citation Analysis]
12 Lin H, Xiao J, Su X, Song B. The Association Between Serum Human Epididymis Protein 4 Level and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease. Lab Med 2021;52:260-6. [PMID: 33009814 DOI: 10.1093/labmed/lmaa076] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Yang K, Wu Y, Chen D, Liu S, Chen R. The Impact of Lung Function on Extra-Pulmonary Diseases and All-Cause Mortality in US Adult Population with and without COPD. Clin Epidemiol 2020;12:997-1005. [PMID: 33061647 DOI: 10.2147/CLEP.S270599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Stringer WW. Are We Treating Heart Failure in Patients with Chronic Obstructive Pulmonary Disease Appropriately? Ann Am Thorac Soc 2020;17:932-4. [PMID: 32735167 DOI: 10.1513/AnnalsATS.202004-395ED] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Aisanov Z, Khaltaev N. Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients. J Thorac Dis 2020;12:2791-802. [PMID: 32642187 DOI: 10.21037/jtd.2020.03.60] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Sugiura T, Dohi Y, Takagi Y, Yokochi T, Yoshikane N, Suzuki K, Tomiishi T, Nagami T, Iwase M, Takase H, Seo Y, Ohte N. Close Association between Subclinical Atherosclerosis and Pulmonary Function in Middle-Aged Male Smokers. J Atheroscler Thromb 2020;27:1230-42. [PMID: 32536635 DOI: 10.5551/jat.55996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Recio Iglesias J, Díez-Manglano J, López García F, Díaz Peromingo JA, Almagro P, Varela Aguilar JM. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. Int J Chron Obstruct Pulmon Dis 2020;15:1015-37. [PMID: 32440113 DOI: 10.2147/COPD.S242009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
18 Riccelli MG, Goldoni M, Poli D, Mozzoni P, Cavallo D, Corradi M. Welding Fumes, a Risk Factor for Lung Diseases. Int J Environ Res Public Health 2020;17:E2552. [PMID: 32276440 DOI: 10.3390/ijerph17072552] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
19 Dubois-Deruy E, Rémy G, Alard J, Kervoaze G, Chwastyniak M, Baron M, Beury D, Siegwald L, Caboche S, Hot D, Gosset P, Grangette C, Pinet F, Wolowczuk I, Pichavant M. Modelling the Impact of Chronic Cigarette Smoke Exposure in Obese Mice: Metabolic, Pulmonary, Intestinal, and Cardiac Issues. Nutrients 2020;12:E827. [PMID: 32244932 DOI: 10.3390/nu12030827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Russo P, Prinzi G, Lamonaca P, Cardaci V, Fini M. Flavonoids and Reduction of Cardiovascular Disease (CVD) in Chronic Obstructive Pulmonary Disease (COPD). Curr Med Chem 2019;26:7048-58. [PMID: 29756566 DOI: 10.2174/0929867325666180514100640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Viglino D, Martin M, Almeras N, Després JP, Coxson HO, Pépin JL, Vivodtzev I, Maltais F; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Low Liver Density Is Linked to Cardiovascular Comorbidity in COPD: An ECLIPSE Cohort Analysis. Int J Chron Obstruct Pulmon Dis 2019;14:3053-61. [PMID: 32099343 DOI: 10.2147/COPD.S233834] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Crisan L, Wong N, Sin DD, Lee HM. Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Front Cardiovasc Med 2019;6:79. [PMID: 31294030 DOI: 10.3389/fcvm.2019.00079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
23 Chioncel O, Collins SP, Ambrosy AP, Pang PS, Antohi EL, Iliescu VA, Maggioni AP, Butler J, Mebazaa A. Improving Postdischarge Outcomes in Acute Heart Failure. Am J Ther 2018;25:e475-86. [PMID: 29985826 DOI: 10.1097/MJT.0000000000000791] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
24 Sato Y, Yoshihisa A, Oikawa M, Nagai T, Yoshikawa T, Saito Y, Yamamoto K, Takeishi Y, Anzai T. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry. J Cardiol 2019;73:459-65. [PMID: 30718015 DOI: 10.1016/j.jjcc.2019.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Chen CY, Liao KM. The impact of atrial fibrillation in patients with COPD during hospitalization. Int J Chron Obstruct Pulmon Dis 2018;13:2105-12. [PMID: 30022816 DOI: 10.2147/COPD.S166534] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]